Aeternum Health 10-Q: Going Concern Warning, Ineffective Controls, and Massive Share Issuance
AETN has more than doubled off its 52-week low of $0.015 on light trading volume (0.3× avg).
Summary
Aeternum Health's 10-Q shows a going concern warning, ineffective disclosure controls, and massive share issuances following its merger and pivot to critical minerals.
Key Events · Earnings and Guidance · AETN
-
Going Concern Warning
With only $702,809 in cash and $1.8M in working capital, the company used $1.6M in operating activities over six months, raising substantial doubt about its ability to continue as a going concern.
-
Ineffective Disclosure Controls
Management concluded that disclosure controls and procedures were not effective as of June 30, 2026.
-
Massive Share Issuance
Subsequent to quarter end, the company issued 49M shares for the merger, 1.92M for a finder's fee, and cancelled 6.63M shares held by Jeff Kim. It also holds an option to acquire 50.1% of the Nkamouna project for 50M shares and 2M Series B preferred.
-
Related Party Funding
Paul Mann loaned $2.17M during the period, bringing total notes payable to him to $2.18M as of June 30, 2026.
Analysis · AETN · Manufacturing
The 10-Q reveals a going concern warning with only $702,809 in cash and $1.6M used in operations over six months. Management also concluded disclosure controls were not effective. Subsequent events show 49M shares issued for the merger, 1.92M for a finder's fee, and 6.63M shares cancelled by Jeff Kim. The company is pivoting to critical minerals and longevity healthcare but faces severe liquidity risk and governance concerns.
At the time of this filing, AETN was trading at $0.16 on OTC in the Manufacturing sector, with a market capitalization of approximately $8.5M. The 52-week trading range was $0.02 to $0.24. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.